Founded by Stéphane Ragusa, who has a qualification from the Ecole Polytechnique and from ENSAE (École nationale de la statistique et de l’administration économique (in English, the National School of Statistics and Economic Administration), as well as a PhD in Biology, Predilife develops innovative solutions in the field of predictive medicine combining proven medical techniques (genetic testing, medical imaging, etc.) and mathematical models using a large amount of statistical data, which could enable individuals to define their risk profile regarding the occurrence of a wide range of serious diseases.
Predilife develops predictive tests for medicine of the future: Predictive, Preventive, Personalised and Participatory (P4). Predictive medicine involves predicting the future of an individual in order to act in a timely manner thanks to personalised prevention, either by lowering the risks (known as primary prevention), or by identifying the illness sooner (secondary prevention). Major diseases, cancers and cardiac arrest in particular, could be prevented in a more effective manner, thereby decreasing their death rate by at least 30%. Still, each person’s health trajectory is needed to act whilst there’s still time.